Respiratory

Latest News

Depemokimab Demonstrates Significant Improvements in Rhinosinusitis with Nasal Polyps
Depemokimab Demonstrates Significant Improvements in Rhinosinusitis with Nasal Polyps

March 3rd 2025

GSK announced its ANCHOR-1 and ANCHOR-2 phase 3 trial results for depemokimab’s efficacy and safety in treating patients with chronic rhinosinusitis with nasal polyps.

Overweight, Obesity, and Asthma Independently Increase Expression of Inflammatory Biomarkers
Overweight, Obesity, and Asthma Independently Increase Expression of Inflammatory Biomarkers

February 25th 2025

FDA Grants Emergency Authorization to Aptitude’s COVID, Flu Test
FDA Grants Emergency Authorization to Aptitude’s COVID, Flu Test

February 24th 2025

FDA Approves MenABCWY Vaccine for Patients Ages 10 to 25 Years
FDA Approves MenABCWY Vaccine for Patients Ages 10 to 25 Years

February 17th 2025

Previously, the drug was granted break through therapy designation by the FDA. | Image Credit: pickup | stock.adobe.com
FDA Grants Priority Review to Brensocatib for Non-Cystic Fibrosis Bronchiectasis

February 6th 2025

Video Interviews
Latest CME Events & Activities

An Overview of Disease Burden Associated With COPD

1.0 Credit / Immunology, Pulmonology/Respiratory

View More

Dual Inhibition in the Management of Moderate to Severe Asthma: Selecting the Appropriate Biologic Therapy Bas...

1.5 Credits / Allergy, Pulmonology, Immunology

View More

Understanding GOLD Updates and Role of Emerging Biologics in COPD Management

1.0 Credit / Immunology, Pulmonology/Respiratory

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Utilizing the Pharmacist to Improve Patient Outcomes in COPD

1.0 Credit / Immunology, Pulmonology/Respiratory

View More

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake

1.0 Credit / Immunization, Infectious Diseases, Pulmonology

View More

Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care

1.5 Credit / Immunology, Pulmonology/Respiratory

View More

Empowering Patients With COPD: The Pharmacist's Role in Personalized Treatment Strategies

1.0 Credit / Pulmonology/Respiratory

View More

More News

© 2025 MJH Life Sciences

All rights reserved.